Ranbaxy releases more dosages for Absorica acne drug
Ranbaxy Laboratories Inc. has launched 25-mg and 35-mg capsules for Absorica (isotretinoin), an acne medication, in the U.S. market.
Latest
CVS Health extends kudos to its pharmacists
CVS Health is saying thanks to its 26,000 pharmacists during October’s American Pharmacists Month for their dedication to serving patients in the company’s retail pharmacies, mail service pharmacies and specialty pharmacies nationwide.
Express Scripts: Walgreens is preferred Part D pharmacy
Express Scripts announced that Walgreen Co. is participating as a preferred pharmacy provider in its two nationally available Medicare Part D prescription drug plans (PDPs) for 2015.
Rite Aid enables video voting for favorite pharmacists
For American Pharmacists Month in October, Rite Aid Corp. has added video voting for its national Vote for Your Favorite Pharmacy Team Member Contest. Rite Aid said Wednesday that through Oct. 31, customers can upload a video nomination at RiteAid.
Salutron unveils LifeTrak R450 wearable life tracker
Salutron Inc., a maker of heart rate monitoring devices and biosensing wearables, has introduced a new line of life trackers to its portfolio, starting with the LifeTrak Brite R450.
Johnson & Johnson to acquire Alios BioPharma
Johnson & Johnson plans to buy Alios BioPharma Inc., a clinical-stage biopharmaceutical company focused on developing therapies for viral diseases, for $1.75 billion in cash. J&J said Tuesday that the acquisition will bolster its current pipeline for viral diseases.
Sprite Cranberry makes a return
By popular demand, Sprite has brought back its Sprite Cranberry and Sprite Cranberry Zero flavors as it heads into the holiday season. The Coca-Cola Co.
HDMA elects Scherr as new board chairman
Ted Scherr, president and chief executive officer of pharmaceutical and health care products wholesaler Dakota Drug Inc., has been elected as chairman of the Healthcare Distribution Management Association (HDMA).
Walgreens meets 4Q, full-year earnings estimates
Adjusted earnings at Walgreen Co. were in line with Wall Street’s forecast for the fiscal 2014 fourth quarter and full year, with the drug chain seeing robust sales gains in both periods.
Perrigo to buy women’s health assets from Lumara
Perrigo Co. plc plans to acquire the women’s health care business of Lumara Health Inc. Perrigo said Tuesday that the $82 million cash deal expands its specialty drug portfolio to include extended topical products in the women’s health.
Mondelez appoints chief marketing officer
Dana Anderson has been promoted to senior vice president and chief marketing officer at Mondelez International.
Council of Ontario College of Pharmacists elects president
The Council of the Ontario College of Pharmacists (OCP) has elected Mark Scanlon as president and Esmail Merani as vice president for the 2014-15 council year. Mark Scanlon OCP said Monday that Scanlon and Merani will each will serve a one-year term from September 2014 through to September 2015.
Coty CEO Scannavini resigns
Michele Scannavini has stepped down as Coty Inc. chief executive officer and resigned from the company’s board of directors. Michele Scannavini Coty said Monday that Scannavini’s departure was due to personal reasons.
Viewpoint: CVS changes retail health care game
In a year crammed with major news stories, cataclysmic personnel shifts and stunning new strategies and directions, the No. 1 retailing story of 2014 increasingly appears to be the CVS decision to stop selling tobacco products in its 7,700 drug stores.
Diplomat Pharmacy begins IPO, names CIO
Diplomat Pharmacy Inc. has commenced an initial public offering and appointed a chief information officer.
Profoot dubs new campaign its biggest ever
Profoot Inc. has kicked off what the company calls its largest integrated marketing campaign.